Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1981 in Antihistamine-Refractory Chronic Idiopathic Urticaria
NCT02031679Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Jan 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timapiprant in chronic idiopathic urticaria (CIU), sponsored by Johns Hopkins University. Started Jan 2014; status: completed.
02
Drugs
timapiprant
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT02031679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02031679.